Christopher Hartl
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$4.4MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $4.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 11, 2025 | NIH | SBIR Phase II Single-cell Epigenome Analysis of the Alzheimer's Disease Brain | $965K | EPIGENOME TECHNOLOGIES, INC. |
| Sep 18, 2024 | NIH | SBIR Phase II Single-cell Epigenome Analysis of the Alzheimer's Disease Brain | $995K | EPIGENOME TECHNOLOGIES, INC. |
| Jun 27, 2024 | NIH | SBIR Phase II High-throughput Single Cell Co-assay of Histone Modifications andTranscriptome | $825K | EPIGENOME TECHNOLOGIES, INC. |
| Jul 3, 2023 | NIH | SBIR Phase II High-throughput Single Cell Co-assay of Histone Modifications andTranscriptome | $1.1M | EPIGENOME TECHNOLOGIES, INC. |
| Sep 16, 2022 | NIH | SBIR Phase I Single-cell Epigenome Analysis of the Alzheimer's Disease Brain | $499K | EPIGENOME TECHNOLOGIES, INC. |
Peer ranks
Federal funding#334
Awards as PI#417
Patents#273
Companies
- EPIGENOME TECHNOLOGIES, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.